-
-
The first U.S. case of MERS-CoV infection diagnosed in the U.S. has been identified in an individual traveling from Saudi Arabia.
-
A Cochrane review questions the value of osletamivir and zanamivir in the treatment of influenza virus infections – but the CDC and IDSA disagree.
-
In a sample of New York City immigrants with dilated cardiomyopathy the point prevalence of infection with Trypanosoma cruzi was found to be 13%.
-
As this issue went to press a second case of MERS was identified in Florida even as the Indiana case was being discharged in good condition. Here is what was known at press time.
-
In a neonatal intensive care unit in Arizona, five infants and ten health care providers were found to have pertussis during a two month period.
-
This study comes from the legacy Multicenter AIDS Cohort Study (MACS) of almost 7000 men who have sex with men, both HIV-infected and non-HIV, for 3 decades.
-
On March 21, 2014, two new antibiotics with activity against methicillin-resistant Staphylococcus aureus (MRSA) each received unanimous recommendations from FDA Advisory Committees for approval for treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive organisms.
-
Infection preventionists remain on heightened alert nationwide afterthe first case of Middle East Respiratory Syndrome (MERS) coronavirus in the United States was recently hospitalized at Community Hospital in Munster, IN.
-
The leading infection control and infectious disease organizations are issuing updated recommendations in new compendium guidelines that will be published in sections over the next few months.
